rs7039117
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000136.3(FANCC):c.-79+22628A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00492 in 1,228,212 control chromosomes in the GnomAD database, including 202 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.022 ( 127 hom., cov: 32)
Exomes 𝑓: 0.0025 ( 75 hom. )
Consequence
FANCC
NM_000136.3 intron
NM_000136.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.430
Publications
1 publications found
Genes affected
FANCC (HGNC:3584): (FA complementation group C) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group C. [provided by RefSeq, Jul 2008]
FANCC Gene-Disease associations (from GenCC):
- Fanconi anemia complementation group CInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Myriad Women’s Health
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- colorectal cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- malignant pancreatic neoplasmInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- ovarian cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0735 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FANCC | NM_000136.3 | c.-79+22628A>G | intron_variant | Intron 1 of 14 | ENST00000289081.8 | NP_000127.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FANCC | ENST00000289081.8 | c.-79+22628A>G | intron_variant | Intron 1 of 14 | 1 | NM_000136.3 | ENSP00000289081.3 |
Frequencies
GnomAD3 genomes AF: 0.0218 AC: 3324AN: 152192Hom.: 127 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
3324
AN:
152192
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00252 AC: 2712AN: 1075902Hom.: 75 AF XY: 0.00228 AC XY: 1208AN XY: 529332 show subpopulations
GnomAD4 exome
AF:
AC:
2712
AN:
1075902
Hom.:
AF XY:
AC XY:
1208
AN XY:
529332
show subpopulations
African (AFR)
AF:
AC:
1830
AN:
24662
American (AMR)
AF:
AC:
120
AN:
23076
Ashkenazi Jewish (ASJ)
AF:
AC:
53
AN:
17242
East Asian (EAS)
AF:
AC:
2
AN:
36134
South Asian (SAS)
AF:
AC:
8
AN:
44710
European-Finnish (FIN)
AF:
AC:
2
AN:
41308
Middle Eastern (MID)
AF:
AC:
23
AN:
4288
European-Non Finnish (NFE)
AF:
AC:
389
AN:
838440
Other (OTH)
AF:
AC:
285
AN:
46042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
126
252
377
503
629
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0219 AC: 3336AN: 152310Hom.: 127 Cov.: 32 AF XY: 0.0206 AC XY: 1535AN XY: 74490 show subpopulations
GnomAD4 genome
AF:
AC:
3336
AN:
152310
Hom.:
Cov.:
32
AF XY:
AC XY:
1535
AN XY:
74490
show subpopulations
African (AFR)
AF:
AC:
3144
AN:
41554
American (AMR)
AF:
AC:
108
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
7
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5186
South Asian (SAS)
AF:
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
AC:
1
AN:
10624
Middle Eastern (MID)
AF:
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
AC:
44
AN:
68020
Other (OTH)
AF:
AC:
23
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
162
325
487
650
812
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.